Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus
- PMID: 40341741
- PMCID: PMC12297247
- DOI: 10.1038/s41422-025-01128-1
Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus
Conflict of interest statement
Competing interests: This study was partially supported by BRL Medicine, Inc.
Figures

References
-
- Mougiakakos, D. et al. N. Engl. J. Med.385, 567–569 (2021). - PubMed
-
- Mackensen, A. et al. Nat. Med.28, 2124–2132 (2022). - PubMed
-
- Müller, F. et al. N. Engl. J. Med.390, 687–700 (2024). - PubMed
-
- Li, M. et al. N. Engl. J. Med.391, 376–378 (2024).
-
- Krickau, T. et al. Lancet403, 1627–1630 (2024). - PubMed
Publication types
LinkOut - more resources
Full Text Sources